Within the 30 (preferably 50) to 100 gram range, we use vitamin C to damage and destroy tumor cells which healthy cells are not affected. We use the pro-oxidative effect of very high doses of vitamin C.
This is also known as biological chemotherapy as well as classical chemotherapy with high-dose vitamin C that is used in the USA as a combined therapy in major hospitals. The prerequisite for this therapy is that a certain enzyme in the blood is sufficiently high. This is checked and inspected before treatment in our laboratory by specialists.
Vitamin C – also called ascorbic acid – is an antioxidant. At high concentration of ascorbic acid, harmful free radicals form which then form poisonous hydrogen peroxide (H2O2). Since in the cancer cells an important degradation enzyme is absent in order to convert the hydrogen peroxide into water and oxygen, they are displaced by the toxic accumulation of the hydrogen peroxide and cannot be converted into apoptosis and necrosis.
Healthy cells remain unaffected by the toxic effects because they have an enzyme that can break down hydrogen peroxide.
It has been proven that cancer patients have a particularly low vitamin C level, which is exacerbated by aggressive radiation treatments and also by chemotherapy. Vitamin C acts only by a high dose of 30-100 grams as an infusion into a vein as a pro-oxidant, to ensure that the cancer cells – and only these, not healthy cells – are harmed. Low-dose vitamin C (eg 7.5 grams) does not have this property.
It is a fact that the additional intake of antioxidants (such as vitamin C in low doses, vitamin E, glutathione, etc) can be omitted, as these substances will be picked up by the cancer cells to protect against the cell destruction. This has nothing to do with the use of these substances in the pre-and after-care, but only during cancer growth.
Many patients experience a sustained improvement in the general condition after only a few vitamin C infusions. Already in 1976 excellent double Nobel laureate Linus Pauling demonstrated the medical impact and success of the vitamin C in patients with cancer.